title: Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years.
abstract: Four patients with sarcoidosis presented as hypothalamic-hypophyseal syndrome including diabetes insipidus (DI) were followed up for more than 8 years from the onset of clinical manifestation. The mean age was 26 years, male : female ratio was 3 : 1 and the mean disease duration of 10 years. All patients had hypogonadism, hyperprolactinemia. Pituitary enlargement with thickening of the pituitary stalk were detected by magnetic resonance imaging (MRI) with gadolinium enhancement and attenuation in the intensity of the posterior lobe of the pituitary was detected without enhancement. Corticosteroid therapy resulted in the initial improvement of symptoms and gradual decrease in the tumor size but failed to cure polyuria due to DI. The use of desmopressin was necessary for a long period. None of these patients died from DI or central neurosarcoidosis.
authors.affiliation: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto 606-8507.
authors.forename: Rollin P
authors.initials: RP
authors.lastname: Tabuena
authors.forename: Sonoko
authors.initials: S
authors.lastname: Nagai
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Handa
authors.forename: Michio
authors.initials: M
authors.lastname: Shigematsu
authors.forename: Kunio
authors.initials: K
authors.lastname: Hamada
authors.forename: Isao
authors.initials: I
authors.lastname: Ito
authors.forename: Takateru
authors.initials: T
authors.lastname: Izumi
authors.forename: Michiaki
authors.initials: M
authors.lastname: Mishima
authors.forename: Om P
authors.initials: OP
authors.lastname: Sharma
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D001927:Brain Diseases / Q000150:complications*; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000209:etiology*; D005260:Female; D006490:Hemostatics / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006966:Hyperprolactinemia / Q000209:etiology; D007006:Hypogonadism / Q000209:etiology; D007027:Hypothalamic Diseases / Q000209:etiology; D008279:Magnetic Resonance Imaging; D008297:Male; D010902:Pituitary Gland / Q000473:pathology; D011379:Prognosis; D012507:Sarcoidosis / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D006490:Hemostatics; D003894:Deamino Arginine Vasopressin